Department of Oncology Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Department of Oncology Surgery, Ninth School of Clinical Medicine, Peking University, Beijing, China.
Oncoimmunology. 2021 May 11;10(1):1923910. doi: 10.1080/2162402X.2021.1923910.
Intestinal epithelial barrier protects intestine from infection and injury, while chronic inflammation is a trigger for tumorigenesis. As a member of tight junctions (TJs) family, Claudin-7 (Cldn-7) is dedicated to maintaining cell polarity and TJs barrier integrity, and closely related to the development of inflammation and tumors. However, potential roles of Cldn-7 in intestinal inflammation and colitis-associated colorectal cancer (CAC) have not been well characterized in vivo. Here, we analyzed the expression profile of Cldn-7 in inflammatory bowel disease (IBD) and CAC. Colitis and colitis-cancer transformation models were established based on inducible intestinal conditional Cldn-7 gene knockout mice (Cldn7fl/fl;villin-CreERT2), by intraperitoneal injection of azomethane (AOM) and dextran sodium sulfate (DSS) feeding. Cldn-7 knockout promoted susceptibility to colitis and CAC, aggravated clinical symptoms, severely damaged intestinal epithelium, increased mucosal inflammation accompanied dysregulated cell proliferation-apoptosis. Epithelial barrier integrity was destroyed, and intercellular permeability was increased. After AOM/DSS induction, tumor burden and volume were increased, characterized by enhanced proliferation and activation of Wnt/β-catenin signaling pathway. Mechanistically, Cldn-7 deficiency promoted colitis and subsequently malignant transformation by destroying TJs integrity and increasing inflammatory cascade. Overall, based on Cldn-7 knockout mouse model, we have first demonstrated the key roles of Cldn-7 in maintaining intestinal homeostasis and preventing IBD and consequent CAC. AJs: adherens junctions; AOM: azomethane; Cldn-7: Claudin-7; CRC: colorectal cancer; CAC: colitis-associated colorectal cancer; CD: Crohn's disease; DSS: dextran sodium sulfate; DAI: disease activity index; EMT: epithelial-mesenchymal transition; FITC: fluorescence isothiocyanate; HB: hemoglobin; IBD: inflammatory bowel disease; IECs: intestinal epithelial cells; ISCs: intestinal stem cells; PLT: platelet; RBC: red blood cell; ROS: reactive oxygen species; TAM: tamoxifen; TJs: tight junctions; TCF/LEF: T-cell factor/lymphoid enhancer factor; UC: ulcerative colitis; WBC: white blood cell.
肠道上皮屏障可保护肠道免受感染和损伤,而慢性炎症是肿瘤发生的诱因。Claudin-7(Cldn-7)作为紧密连接(TJs)家族的一员,致力于维持细胞极性和 TJs 屏障完整性,与炎症和肿瘤的发展密切相关。然而,Cldn-7 在肠道炎症和结肠炎相关结直肠癌(CAC)中的潜在作用尚未在体内得到很好的描述。在这里,我们分析了 Claudin-7 在炎症性肠病(IBD)和 CAC 中的表达谱。基于诱导型肠道条件性 Cldn-7 基因敲除小鼠(Cldn7fl/fl; villin-CreERT2),通过腹腔注射偶氮甲烷(AOM)和葡聚糖硫酸钠(DSS)喂养,建立了结肠炎和结肠癌转化模型。Cldn-7 敲除促进结肠炎和 CAC 的易感性,加重临床症状,严重破坏肠道上皮,增加黏膜炎症伴细胞增殖-凋亡失调。上皮屏障完整性被破坏,细胞间通透性增加。AOM/DSS 诱导后,肿瘤负担和体积增加,表现为 Wnt/β-catenin 信号通路的增殖和激活增强。机制上,Cldn-7 缺失通过破坏 TJs 完整性和增加炎症级联反应促进结肠炎的发生和随后的恶性转化。总体而言,基于 Cldn-7 敲除小鼠模型,我们首次证明了 Cldn-7 在维持肠道内稳态和预防 IBD 及随后的 CAC 中的关键作用。AJs:黏附连接;AOM:偶氮甲烷;Cldn-7:Claudin-7;CRC:结直肠癌;CAC:结肠炎相关结直肠癌;CD:克罗恩病;DSS:葡聚糖硫酸钠;DAI:疾病活动指数;EMT:上皮-间充质转化;FITC:荧光异硫氰酸酯;HB:血红蛋白;IBD:炎症性肠病;IECs:肠道上皮细胞;ISCs:肠道干细胞;PLT:血小板;RBC:红细胞;ROS:活性氧;TAM:他莫昔芬;TJs:紧密连接;TCF/LEF:T 细胞因子/淋巴增强因子;UC:溃疡性结肠炎;WBC:白细胞。